0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Observation  | 
Paracentral Acute Middle Maculopathy in Sickle Cell Disease
Tomas Ilginis, MBBS; Pearse A. Keane, MD, FRCOphth; Adnan Tufail, MD, FRCOphth
JAMA
News From the Centers for Disease Control and Prevention  | 
Sickle Cell Disease Screening Offers Educational Opportunity for Parents

JAMA
Editorial  | 
Telomere Length in Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia:  Is It Ready for “Prime Time”?
Ayman Saad, MD; Shin Mineishi, MD; Racquel Innis-Shelton, MD
JAMA
Original Investigation  | 
Association Between Donor Leukocyte Telomere Length and Survival After Unrelated Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia
Shahinaz M. Gadalla, MD, PhD; Tao Wang, PhD; Michael Haagenson, MS; et al.